PAT-1251
PAT-1251 is a LOXL2 inhibitor exhibiting IC50 values of 10 μM (mouse), 0.12 μM (rat), and 0.16 μM (dog) . It serves as a research tool for investigating fibrotic diseases in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2007885-39-2
Product Name Alternative
2098884-52-5, Dog LOXL2, hLOXL2, hLOXL3, Lenumlostat, Monoamine Oxidase, MonoamineOxidase, Mouse LOXL2, PAT 1251, PAT-1251, PAT1251, LOXL2, Rat LOXL2
Field of Research
Neuroscience
Purity
97.27% (May vary between batches)
Solubility
H2O:100 mg/mL (250.41 mM) ; DMSO:100 mg/mL (250.41 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.02 mM)
Smiles
NCc1cc (Oc2cccc (c2) C (=O) N2C[C@@H] (O) [C@H] (F) C2) nc (c1) C (F) (F) F
Molecular Formula
C18H17F4N3O3
Molecular Weight
399.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
123182-FITC 100 µL
AKT3 (RAC-gamma Serine/Threonine-protein Kinase, Protein Kinase Akt-3, Protein Kinase B gamma, PKB gamma, RAC-PK-gamma, STK-2, PKBG) (FITC)
Sign In for Pricing
View Details GTR15083522 1 Vial
Lentiviral human DOCK4 shRNA (UAS) - Lentiviral human DOCK4 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 